Clorox stock drops more than 4% after new institutional stake and mixed technical signals fail to stop slide

Traders Union
All News
Stocks
Clorox slides 4.38% today to $98.08

Highlights

Ferguson Wellman Capital Management acquired 7,100 shares of Clorox after the company raised its dividend to $5.00 per share, giving a yield of 4.9%.
Clorox quarterly earnings were $1.66 per share, slightly outperforming consensus, with revenues reported at $1.95 billion.
Shares of Clorox trade below key moving averages with weak trend readings, oversold indicators, and a 5-day price range of $93.86 to $100.18.

Dividend increase and new stake countered by sustained institutional sell-off

Ferguson Wellman Capital Management Inc. purchased a new stake of 7,100 shares in Clorox, according to a recent SEC 13F filing. The company reported an annualized dividend of $5.00 per share, reflecting a yield of approximately 4.9% and an increase from its previous quarterly payout. Quarterly earnings came in at $1.66 per share, slightly above consensus, with business revenues of $1.95 billion. Institutional investors and hedge funds hold about 78.53% of Clorox's stock, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, believes Clorox is showing persistent technical and fundamental weakness. Despite increased institutional involvement and a dividend boost, sellers remain firmly in control. The price now trades below all major moving averages, confirming a bearish structure and short-term breakdown. Oversold signals have not attracted buyers, signaling poor sentiment. "Until Clorox reclaims $100.18 and builds sustained momentum, I see further downside risk as dominant," Kharitonov says.

Viktoras Karapetjanc, expert at Traders Union, sees encouraging fundamentals for Clorox despite the price setback. The boost in annualized dividend and strong institutional ownership point to resilient core investor confidence. He notes that the current volatility presents attractive entry opportunities for longer-term holders. The robust yield and above-consensus earnings bolster the longer-term bullish case. "With the bullish structure supported by fundamentals, I expect further growth as investors capitalize on these levels," says Karapetjanc.

Jainam Mehta, market strategist, notes that Clorox’s price action is stuck between key support at $93.86 and resistance at $100.18. The mix of oversold readings and ongoing selling pressure creates a tactical battleground. He sees a sideways movement scenario unless a breakout closes above resistance or below support. "There may be a potential contrarian opportunity if sentiment improves near oversold levels," Mehta suggests.

Mixed momentum signals as price holds below key resistance levels

Clorox is trading below all major moving averages, with the latest price at $98.08 versus the MA-20 at $105.4, MA-50 at $99.76, and MA-200 at $103.39. This setup indicates persistent seller pressure across short-, medium-, and long-term horizons, with the near-term ceiling at $98.35 and floor at $93.86. Momentum readings are mixed: the MACD signals strong buy, ADX at 19.56 is neutral, while RSI at 47.79 and CCI at -94.55 both register a sell bias. Stochastic RSI shows oversold conditions at 0, and Bull/Bear Power at 0.15 points to slight intraday buyer dominance, though this is muted amid overall selling. The stock declined by $4.495, or 4.38% today, after a downside gap of about $1.21 (1.18%), trading near session lows. Intraday volatility stands at 3.11%. The tone remains weak, with sellers in control after the open despite some oversold signals.

Earlier, analysts noted that Clorox was displaying short- and medium-term technical strength but continued to face mixed longer-term signals. The current shift to sustained pressure below all major moving averages introduces a more cautious backdrop, with traders advised to watch $93.86 as a potential downside risk level in the coming sessions.

Source of Data: CLX Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.